日韩色综合-日韩色中色-日韩色在线-日韩色哟哟-国产ts在线视频-国产suv精品一区二区69

手機(jī)APP下載

您現(xiàn)在的位置: 首頁(yè) > 在線廣播 > VOA慢速英語(yǔ) > VOA慢速-健康報(bào)道 > 正文

VOA慢速英語(yǔ)(翻譯+字幕+講解):美國(guó)批準(zhǔn)首個(gè)針對(duì)埃博拉病毒的療法

來(lái)源:可可英語(yǔ) 編輯:aimee ?  可可英語(yǔ)APP下載 |  可可官方微信:ikekenet
  


掃描二維碼進(jìn)行跟讀打分訓(xùn)練
zIwybi0f7u

U&%ug0g^DWz3KM(x

US Approves First Treatment for Ebola Virus
The United States Food and Drug Administration (FDA) has approved the world's first treatment for the deadly Ebola virus.
The treatment, Inmazeb, is a combination of three genetically-engineered antibodies. The company Regeneron Pharmaceuticals developed it to treat both young and old patients with the virus version called Zaire Ebola. It is the deadliest kind of Ebola known to infect humans. Zaire Ebola usually kills 60 to 90 percent of patients.
FDA officials announced the approval of Inmazeb on Wednesday.
The Zaire Ebola virus can spread easily through direct contact with body fluids of infected people or animals. Signs of the disease include increased body temperature, pain, stomach sickness, kidney and liver damage, and bleeding. People who provide care to infected individuals are at highest risk of contracting the virus.
Regeneron's drug was one of four tested during a Zaire Ebola outbreak in Congo between 2018 to 2019. The outbreak killed almost 2,300 people.
Regeneron received support from the U.S. National Institutes of Health and international health agencies.
The study involved 681 people infected with the virus. After four weeks, about one-third of 154 patients who received Inmazeb had died. Similar results were reported for a group that got a different drug. But, about half the patients died among the other two groups given one of the other two drugs.
The study ended early last year so all patients could get Inmazeb.

7M[.5(Ykq_^WZywLj!!

埃博拉病毒.jpeg
Leah Lipsich leads Regeneron's infectious diseases program. She said, "When you have three drugs that bind to the (virus), there's a low probability that the virus can evade all of them."
Lipsich noted that the FDA's approval will make it easier for the company to get permission to use the drug during outbreaks in African countries.
George D. Yancopoulos is Regeneron's chief scientific officer. He said the drug maker is using the same technology to develop an antibody drug to treat COVID-19. He said in a statement, "we hope this will be one of many demonstrations of how the power of science can be successfully deployed against dangerous infectious diseases."
The antibody combination technology has also been used to develop drugs to treat HIV, the cause of AIDS. Regeneron and drug maker Eli Lilly are now asking the FDA to permit emergency use of experimental engineered antibody medicine to treat patients with COVID-19.
The FDA approved the first vaccine for Ebola last December. That drug, Ervebo, is made by Merck.
I'm Caty Weaver.

,N^U4(lPXTD#l

+C,ZgBeKw&@piHKIzvkf%R~%5oOpSxP[-fyuLTJvqq

重點(diǎn)單詞   查看全部解釋    
experimental [iks.peri'mentl]

想一想再看

adj. 實(shí)驗(yàn)(性)的,試驗(yàn)(性)的

 
antibody ['ænti.bɔdi]

想一想再看

n. 抗體

聯(lián)想記憶
announced [ə'naunst]

想一想再看

宣布的

 
probability [.prɔbə'biliti]

想一想再看

n. 可能性,或然率,機(jī)率

聯(lián)想記憶
kidney ['kidni]

想一想再看

n. 腎,腰子,類型

 
permit ['pə:mit,pə'mit]

想一想再看

n. 許可證,執(zhí)照
v. 允許,許可

聯(lián)想記憶
statement ['steitmənt]

想一想再看

n. 聲明,陳述

聯(lián)想記憶
approval [ə'pru:vəl]

想一想再看

n. 批準(zhǔn),認(rèn)可,同意,贊同

聯(lián)想記憶
vaccine ['væksi:n]

想一想再看

n. 疫苗

 
administration [əd.mini'streiʃən]

想一想再看

n. 行政,管理,行政部門

聯(lián)想記憶
?
發(fā)布評(píng)論我來(lái)說(shuō)2句

    最新文章

    可可英語(yǔ)官方微信(微信號(hào):ikekenet)

    每天向大家推送短小精悍的英語(yǔ)學(xué)習(xí)資料.

    添加方式1.掃描上方可可官方微信二維碼。
    添加方式2.搜索微信號(hào)ikekenet添加即可。
    主站蜘蛛池模板: 秦皇岛电视台| 白世莉电影| 国土防线| 白洁少妇董汐星空传媒影视| 麦当娜简历| 少女免费观看完整电视电影| doors2怪物图鉴| 男女拔萝卜免费视频| 黄明昊身高| 杨欣悦| 好好说再见| 山巅之城| 离歌吉他谱| 国产伦理电影在线观看| 韩奕| 电影疯狂之人| 扭曲的欲望| 在线黄色片| 刘慧茹| 舞出我的人生| 相信我们会创造奇迹的歌词| 女生被草视频| 上春山歌词| 电影百度百科| 你们可知道正谱| 马德哈万| 大胆写真| 西街少年 电视剧| 寄诚庸| 光遇安卓官服下载| 彭丹露点| 欲海情缘| 李慧珍演的电影有哪些| 恩乔| 琉璃演员表全部演员介绍| 雀圣 电影| 麻辣烫热量| 雷电影| 聊斋电影| 北京宝哥打小混混视频| 张国强个人简历|